跳至主要内容
临床试验/ACTRN12609000001291
ACTRN12609000001291尚未招募3 期

Effect of new remedy drug IMOD[Immunomodulating drug] on the mortality of patients with severe sepsis. A phase III multicenter study

pars rus0 个研究点目标入组 60 人开始时间: 2009年1月6日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Severe sepsis with APACHE (Acute Physiology And Chronic Health Evaluation)Score>20 with less than 24 hours after their diagnosis.

排除标准

  • pregnant or lactating person, Age less than 16 years old, high death possibility within 24-48 hours and previous organ transplantation and receiving immunosuppressant drugs.

研究者

发起方
pars rus

相似试验

尚未招募
2 期
Evaluating the effect of new remedy IMOD (Imunomodulating Drug)in the treatment of adult patients with sever sepsis
ACTRN12607000376448Tehran University of Medical Sciences,faculty of pharmacy25
撤回
2 期
Clinical and immunological effects of imiquimod and HPV-vaccination compared to imiquimod alone in female patients with Usual type VIN: proof of principle.precancerous lesion of the vulvaeVulvar Intraepithelial neoplasia100474381003858810040785
NL-OMON33950Erasmus MC, Universitair Medisch Centrum Rotterdam98
进行中(未招募)
不适用
Clinical and immunological effects of imiquimod and HPV-vaccination compared to imiquimod alone in female patients with Usual type VIN - Effects of HPV-vaccination and imiquimod in VIN patientsIn this trial, the efficacy of Gardasil combined with imiquimod in women with usual type Vulvar Intraepithelial Neoplasia is investigated.MedDRA version: 9.1Level: LLTClassification code 10047778Term: Vulvar cancer in situMedDRA version: 9.1Level: LLTClassification code 10066416Term: Vulvovaginal human papilloma virus infectionMedDRA version: 9.1Level: LLTClassification code 10046859Term: VaccinationMedDRA version: 9.1Level: LLTClassification code 10062059Term: Histology abnormal
EUCTR2008-008251-42-NLErasmus MC
已完成
3 期
The effect of adding IMOD Iranian drug in HIV-positive patientsAIDS.Human immunodeficiency virus [HIV] diseaseB20-B24
IRCT2015070423046N1Vice chancellor for research Of Qom Branch Of Islamic Azad University - Counseling Center for Behavi60
尚未招募
不适用
Effect of the drug â??Immuneâ??- an Ayurveda medication in COVID-19 patients
CTRI/2020/10/028471GR Vishnu Sri